Charles River (NYSE: CRL) Lowers 2024 Forecast, Stock Slumps
On Thursday, contract drug developer Charles River Laboratories (NYSE: CRL) cut its annual forecasts as it warned of worsening demand […]
Charles River (NYSE: CRL) Lowers 2024 Forecast, Stock Slumps Read More »